Discovery of drug candidate to potentially tackle ER-positive breast cancer

An international team of researchers, led by Pfizer in collaboration with Monash University and the Australian-based Cancer Therapeutics Cooperative Research Centre, have discovered a pre-clinical drug candidate demonstrating anti-tumour activity in

Related Keywords

,Shikhar Sharma ,Brendon Monahan ,Thomas Paul ,Paul Stupple ,Alan Robertson ,Monash University ,Centre For Drug ,Cancer Therapeutics Cooperative Research Centre ,Pfizer Research ,Monash Institute Of Pharmaceutical Sciences ,Pfizer ,Oestrogen Receptor ,Cell Chemical Biology ,Medicinal Chemistry ,Monash Institute ,Pharmaceutical Sciences ,Professor Paul Stupple ,Chief Scientific Officer ,Cancer Therapeutics ,Medchem Australia ,Professor Brendon Monahan ,Drug Candidate Optimisation ,Professor Susan Charman ,Managing Director ,Canthera Discovery ,Pfizer Research Fellow ,Senior Director ,Drug Candidate ,